Skip to main content
JAMA Network logoLink to JAMA Network
. 2023 May 1;177(6):567–581. doi: 10.1001/jamapediatrics.2023.0846

Changes in Depression and Anxiety Among Children and Adolescents From Before to During the COVID-19 Pandemic

A Systematic Review and Meta-analysis

Sheri Madigan 1,2,, Nicole Racine 3,4, Tracy Vaillancourt 3,5, Daphne J Korczak 6,7, Jackson M A Hewitt 1,2, Paolo Pador 1, Joanne L Park 1,2, Brae Anne McArthur 1,2, Celeste Holy 1, Ross D Neville 8
PMCID: PMC10152379  PMID: 37126337

Key Points

Question

Did depression and anxiety symptoms increase in cohorts of children and adolescents monitored before and during the COVID-19 pandemic?

Findings

This systematic review and meta-analysis of 53 longitudinal studies including more than 40 000 children and adolescents across 12 countries found an increase in depression symptoms during the COVID-19 pandemic, particularly among female individuals and those from relatively higher-income backgrounds. Anxiety symptoms increased slightly during the pandemic, although there was some evidence of a small increase in anxiety symptoms for children and adolescents from relatively higher-income backgrounds.

Meaning

The findings of longitudinal changes in child and adolescent mental health during the COVID-19 pandemic in this study can inform policy and public health responses to address mental health concerns.


This systematic review and meta-analysis evaluates depression and anxiety among children and adolescents during vs before the COVID-19 pandemic.

Abstract

Importance

There is a growing body of high-quality cohort-based research that has examined changes in child and adolescent mental health during the COVID-19 pandemic vs before the pandemic. Some studies have found that child and adolescent depression and anxiety symptoms have increased, while others have found these symptoms to have remained stable or decreased.

Objective

To synthesize the available longitudinal cohort-based research evidence to estimate the direction and magnitude of changes in depression and anxiety symptoms in children and adolescents assessed before and during the pandemic.

Data Sources

Medline, Embase, and PsycInfo were searched for studies published between January 1, 2020, and May 17, 2022.

Study Selection

Included studies reported on depression and/or anxiety symptoms, had cohort data comparing prepandemic to pandemic estimates, included a sample of children and/or adolescents younger than 19 years, and were published in English in a peer-reviewed journal.

Data Extraction and Synthesis

In total, 53 longitudinal cohort studies from 12 countries with 87 study estimates representing 40 807 children and adolescents were included.

Main Outcomes and Measures

Standardized mean changes (SMC) in depression and anxiety symptoms from before to during the pandemic.

Results

The analysis included 40 807 children and adolescents represented in pre–COVID-19 studies and 33 682 represented in during–COVID-19 studies. There was good evidence of an increase in depression symptoms (SMC, 0.26; 95% CI, 0.19 to 0.33). Changes in depression symptoms were most conclusive for study estimates among female individuals (SMC, 0.32; 95% CI, 0.21 to 0.42), study estimates with mid to high income (SMC, 0.35; 95% CI, 0.07 to 0.63), and study estimates sourced from North America (SMC, 0.25; 95% CI, 0.15 to 0.36) and Europe (SMC, 0.35; 95% CI, 0.17 to 0.53). There was strong evidence that anxiety symptoms increased slightly during the pandemic (SMC, 0.10; 95% CI, 0.04 to 0.16), and there was some evidence of an increase in study estimates with mid to high income.

Conclusions

This systematic review and meta-analysis of longitudinal studies including children and adolescents found an increase in depression symptoms during the COVID-19 pandemic, particularly among female individuals and those from relatively higher-income backgrounds.

Introduction

There has been considerable debate as to whether the mental health of children and adolescents has been impacted by the disruptions and restrictions introduced during the COVID-19 pandemic. A meta-analysis by Racine et al1 with 29 cross-sectional studies and more than 80 000 individuals found that 25.2% of children and 20.5% of adolescents reported clinically elevated (ie, moderate to severe) depression (eg, sadness, hopelessness, and mood lability) and anxiety (eg, excessive worry and fear) symptoms during the pandemic. Although this meta-analysis1 was valuable for highlighting the potential deterioration of mental health in children and adolescents during a global crisis, researchers have warned against heavy reliance on cross-sectional data for driving policy decisions, as they are prone to methodological biases.2

Longitudinal cohort studies of children and adolescents with data collected both before and during the COVID-19 pandemic provide more reliable information about the state of child and adolescent mental health.2 These studies were slower to emerge during the pandemic compared to cross-sectional snapshots of depression and anxiety symptoms during the COVID-19 pandemic. Meta-analyses of longitudinal changes in the general mental health of young people during the pandemic have been published.3,4 A meta-analysis5 of change in depression and anxiety symptoms during the pandemic across population groups has also been published; however, the findings specific to children and adolescents aged 10 to 19 years were from a small sample of studies (k = 8 for depression symptoms; k = 10 for anxiety symptoms) in children aged 10 to 19 years only, and lacked adjustment for baseline pre–COVID-19 symptoms.

There are many reasons to expect changes in depression and anxiety symptoms among children and adolescents during the pandemic. Social isolation and quarantine orders have been associated with a 4-fold increased risk in stress-related symptoms among children.6 Numerous etiological factors for psychopathology also appeared or were exacerbated during the pandemic, including increased screen time,7 closures and disruptions related to schooling,8,9 cancellation of extracurricular activities,9 increased loneliness,10 decreased physical activity,11 and lack of access to school mental health supports.12 Commensurate with these risk factors were considerable changes to the family milieu, which can have spillover effects on child and adolescent well-being,13,14 such as increases in parent depression and anxiety symptoms,15,16 family violence,17 job loss, and alcohol consumption.18 However, longitudinal cohort studies examining changes from before to during the pandemic have revealed a range of different findings: some studies reported that depression and anxiety symptoms have decreased19,20 or remained stable,21,22 while others showed various levels of increase.23,24,25 When study results are inconsistent, it can cast doubt on the reliability of findings, thus slowing or even halting the adoption or integration of mental health policy changes aimed at supporting children and adolescents.26

The primary aim of this study was to provide a comprehensive synthesis of longitudinal cohort studies comparing prepandemic estimates of depression and anxiety symptoms in children and adolescents to pandemic estimates. The secondary objective was to estimate whether the direction and magnitude of changes differed by sex, age, race, ethnicity, income, and geographical region. An examination of moderating variables was considered critical because some groups may be at greater risk of mental distress, including female individuals,27,28,29 adolescents (vs younger children),1,30 racial and ethnic minoritized groups,31,32 and people from lower income backgrounds.33,34,35

Methods

Search Strategy

Using Medline, Embase, and PsycInfo, we searched for studies published between January 1, 2020, and May 17, 2022 (eTable 1 in Supplement 1). Search terms were related to mental health (eg, depress** and anxiet*), coronavirus (eg, COVID-19), and pediatric populations (eg, child* and adolescen*). We hand-searched reference lists of studies meeting our inclusion criteria to identify other relevant studies. This review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline (eFigure 1 in Supplement 1)36,37 and was registered with PROSPERO (CRD42022341897).

Selection Criteria

All retrieved titles and abstracts were imported into Covidence software. Studies were included if they reported on depression or anxiety symptoms using validated measures, had data comparing prepandemic to pandemic estimates, included pediatric samples (younger than 19 years), and were published in English in a peer-reviewed journal. Exclusion criteria were qualitative analyses, unpublished preprints, case studies, or reports. A minimum of 2 coders independently screened each title or abstract (mean random agreement probability: 92%). Two coders independently screened full-text articles meeting initial screening (mean random agreement probability: 88%). Discrepancies were resolved via discussion and consensus.

Data Extraction

We extracted the pre– and during–COVID-19 sample means and SDs for depression and anxiety symptoms, as well as predicted mean changes and inferential statistics (ie, change-score SD, P value, or 95% CI to calculate the SEs of these mean changes). We also extracted study characteristics (ie, study design, sample size, and duration of time between pre– and during–COVID-19 assessments), sample characteristics (geographical region, median age, sex, race, ethnicity, percentage with clinical diagnosis or medical condition, and the income of the sample, categorized by the original study authors as having low or mid to high income), and methodological characteristics (child-, parent-, or clinician-reported data and study quality criteria). Race and ethnicity were reported to account for the possibility that some racial and ethnic minoritized groups may be at greater risk of mental health issues. Racial and ethnic groups are reported according to the original studies and included American Indian or Alaska Native, Asian, Black, Hispanic, and White. Two coders independently conducted data extraction. Intercoder agreement was 87%. Discrepancies were resolved via discussion and consensus.

Study Quality

We used an adapted version of the National Institutes of Health Quality Assessment Tool for Observation Cohort and Cross-Sectional Studies38 (eTables 2-3 in Supplement 1). All studies meeting full inclusion criteria were scored 1 (criterion met) or 0 (criterion unmet) for 10 criteria and summed to a score between 0 and 10 with higher scores indicating better study quality.

Data Preparation and Analysis

Standardized mean changes (SMCs) in depression and anxiety symptoms were calculated following the principle of standardization39—that is, by subtracting the study estimate pre–COVID-19 means for depression and anxiety from their corresponding during–COVID-19 values, and then dividing these values by their respective pre–COVID-19 SDs. The SEs for SMCs were mostly calculated from their corresponding P values or 95% CIs. When both the pre– and during–COVID-19 SD or SE of depression and anxiety symptoms were reported in a study (but not the P value or 95% CI for mean changes), the formula for imputing SDs for changes from baseline was used to derive a change-score SE.40

Two separate random-effects meta-analyses were performed in SAS OnDemand for Academics version 9.4 (SAS Institute). The inverse variance method was used to weight each meta-analysis.41 In both meta-analyses, a single study identity random effect was estimated to account for between-study heterogeneity. This heterogeneity was evaluated as the magnitude of the τ statistic,42 which represents the average difference in the SMC between studies. Categorical moderators were sex, age, income (ie, study estimates of individuals coded by study authors as having low or mid to high income), and geographical region. Continuous moderators were baseline depression or anxiety symptoms, study quality, race, and ethnicity (the moderating influence of race and ethnicity was calculated by comparing the changes in depression and anxiety symptoms between study estimates with higher and lower proportions of individuals from a racial or ethnic minoritized heritage). The discrepancy in symptom reporting between children, adolescents, parents, or caregivers was controlled for using a dummy variable and a numeric value for informant held constant at its mean.

The results for categorical moderators represent SMCs calculated at different values or at different levels of the moderator. SMCs for samples of male and female individuals were calculated at values of 0 and 100, respectively, for the moderator female (ie, since the moderator female represented the proportion of female individuals in each study). SMCs for children and adolescents were calculated from study estimates with median ages less than 12 years and greater than 12 years, respectively. SMCs for different geographical regions and different income were calculated using dummy variables (eg, a value of 1 identifying study estimates from North America as distinct from the remaining study estimates, which were given a value of 0, and a value of 1 identifying study estimates with mid to high income as distinct from those characterized as having low income). The results for continuous moderators represent the difference in the SMC in anxiety symptoms between study estimates with below average (mean −1 standard deviation) and above average (mean +1 standard deviation) values for the moderator.43 The results for each individual moderator were calculated with the remaining moderators held constant at their mean values.

Thresholds for slight, small, moderate, large, and very large SMCs and moderating associations were 0.2, 0.6, 1.2, and 2.0 standardized units, respectively.43 Sampling uncertainty was deemed inadequate when the 95% CI included substantial positive and negative values (ie, values ±0.2 standardized units).44,45,46 The extent of overlap of the 95% CIs with slight or substantial (ie, small, moderate, and large) values was used to assess the level of evidence for or against the magnitude of the SMC and its moderators, as described in eTable 4 in Supplement 1. Probabilities representing the chances that the SMCs in depression and anxiety and their moderators were substantially negative, slight, or substantially positive are listed in full in eTables 5 and 6 in Supplement 1.

Publication Bias and Outliers

Publication bias was assessed by visually inspecting scatterplots of the random-effect solutions from the meta-analyses and the SE for each study estimate. Random-effect solutions with a P value less than .05 divided by the degrees of freedom for this residual value were considered statistical outliers.6,11

Results

A total of 6822 nonduplicate records were identified by our search strategy, 351 of which were screened for inclusion. Fifty-three studies met the full inclusion criteria (eFigure 1 in Supplement 1), from which 87 study estimate SMCs were extracted (49 SMCs in depression and 38 SMCs in anxiety symptoms).

Study Characteristics

Across the 53 studies (Table 1), 40 807 children and adolescents were represented during COVID-19. The mean (SD; range) age for study estimates of changes in depression and anxiety symptoms were 13.5 (2.4; 4.6-17.5) years and 12.6 (3.7; 3.3-17.5) years, respectively. The proportions of female individuals in studies of changes in depression and anxiety symptoms were 54% and 52%, respectively. In terms of informant, 46 individuals (87%) were self-report, 5 (9%) were parent-report, 1 (2%) was parent and child report, and 1 (2%) did not report the informant. Twenty-seven studies reported data from North America (51%), 13 (24%) from Europe, 10 (19%) from Asia, 2 (4%) from Australia, and 1 (2%) from Israel. The mean (range) study quality score was 7.5 (5-10).

Table 1. Characteristics of the Included Studies.

Source Individuals, No. Age, mean (SD) y Female, No. (%) Country Individuals in racial and ethnic minoritized groups,a % Outcome Measure Informant Data collection dates
Before COVID-19 During COVID-19 Before COVID-19 During COVID-19
Adegboye et al,23 2021 142 142 6.2 (5.0-10.0)b 45 (32) UK 17 Anxiety SCARED Parent March 2017 July 2020
Alt et al,47 2021 739 739 16.1 (14.0-17.0)b 327 (58) Germany NR Depression STDS Child October 2018 May 2020
Bano et al,48 2022 25 25 13.0 (11.0-15.0)c 9 (35) US 24 Depression PHQ-9 Child August 2019 August 2020
Anxiety GAD-7
Bélanger et al,49 2021 7354 1880 14.1 (0.1) 3898 (53) Canada 17 Depression CESDR-10 Child 2018 and 2019 May 2020
Anxiety GAD-7
Bignardi et al,24 2021 168 168 8.6 (0.6) 88 (52) UK NR Depression RCADS Child and parent June 2018 April 2020
Anxiety
Bouter et al,50 2022 445 445 17.7 (0.7) 266 (60) Netherlands 14 Depression YSR ASEBA Child April 2020 January 2021
Anxiety
Breaux et al,22 2021 238 238 15.0-17.0c 106 (45) US 12 Depression RCADS Child September 2018 May 2020
Anxiety
Caha,51 2022 148 108 17.1 (1.5) 77 (52) US NR Depression MASQ Child NR NR
Anxiety
Cantiani et al,52 2021 90 90 2.0-6.0c 39 (34) Italy NR Anxiety CBCL Parent February 2020 April 2020
Charmaraman et al,53 2022 586 586 12.5 (1.2) 311 (53) US 43 Depression CESDR-10 Child October 2019 October 2020
Chavarria et al,54
2021
258 258 13.2 (2.0-18.0)b 139 (54) US NR Depression PHQ-9 NR NR NR
Anxiety GAD-7
Chen et al,55 2022 575 575 10.8 (0.8) NR China NA Depression DASS-21 Child January 2020 March 2020
Anxiety
Cohen et al,56 2021 24 24 14.8 (1.2) 14 (58) US 37 Depression PROMIS Child August 2019 May 2021
Anxiety
Defrance et al,57 2022 184 136 13.9 (0.8) 93 (50) Canada 8 Depression CDI Child NR NR
Anxiety MASC
Duttweiler et al,58
2022
53 53 12.5 (2.3) 41 (77) US 47 Depression CDI Child NR June and September 2020
Anxiety SCARED
Ertanir et al,59 2021 377 319 12.7 (0.7) 99 (47) Switzerland NR Depression HSCL-25 Child September 2019 August 2020
Anxiety
Feurer et al,60 2022 29 29 12.6 (2.4) 24 (83) US 41 Depression CES-D Child NR June and September 2020
Anxiety SCARED
Gadassi Polack et al,61 2021 112 112 11.8 (2.1) 62 (55) US NR Depression CDI-S Child January 2019 March 2020
Giménez-Dasí et al,62 2020 113 113 7.2 (2.6) 47 (42) Spain NR Depression SENA Parent February 2020 April 2020
Giménez-Dasí et al,63 2021 133 42 8.5 (1.7) 69 (52) Spain NR Anxiety SENA Child December 2019 December 2020
Gladstone et al,64 2022 228 228 14.5 (1.6) 121 (53) US 27 Depression PHQ-A Child November 2019 May 2020
Hawes et al,65 2022 451 451 17.5 (1.4) 295 (65) US 17 Depression CDI Child March 2019 March 2020
Anxiety SCARED
He et al,66 2022 1687 1687 12.5 (0.5) 668 (40) China NA Depression CES-DC Child October 2019 October 2020
Hite et al,25 2021 258 258 NR NR US NR Depression PHQ-9 Child and clinician NR NR
Anxiety GAD-7
Hollenstein et al,67 2021 178 146 12.5 (12.0-13.0)b 77 (43) Canada NR Depression CDI-2 Child September 2019 May 2020
Anxiety BAI
Houghton et al,68 2022 785 785 14.1 (1.3) 454 (58) Australia NR Depression CDI-2 Child October 2019 June 2020
Huang et al,69 2021 26 26 8.0-17.0c 16 (62) US NR Depression PROMIS Child 2019 2020
Janssen et al,70 2020 34 34 16.0 (1.2) 22 (65) Netherlands NR Depression PHQ-9 Child September 2018 April 2020
Kwok et al,71 2022 50 50 14.4 (3.2) 28 (56) Canada NR Depression CDI-2 Child November 2018 August 2020
Anxiety MASC-2
Li et al,72 2021 1020 831 15.9 (0.7) 601 (59) China NA Depression BDI-2 Child December 2019 March 2020
Anxiety ZSRAS
Li et al,20 2022 621 621 14.4 (11.0-17.0)b 313 (50) China NA Depression GEAS Child 2018 January to June 2020
Liao et al,73 2021 2496 2496 13.4 (0.9) 1253 (50) China NA Depression CES-DC Child December 2019 July 2020
Liu et al,74 2022 175 86 16.0 (2.6) 86 (49) US 57 Depression CDI-2 Child 2015 to 2018 April to May 2020
Magson et al,75 2021 248 248 14.4 (0.5) 126 (51) Australia 18 Depression SMFQ-C Child 2019 May 2020
Anxiety SCAS-C
McArthur et al,7 2023 846 846 10.0 (9.0-11.0)b 398 (47) Canada 17 Depression BASC-2 Child January 2017 July 2020
Anxiety BASC-3
Menter et al,76 2022 109 109 4.6 (0.5) 59 (54) Canada 15 Depression CASI Parent September 2019 May 2020
Anxiety
Mlawer et al,77 2022 96 96 16.0 (0.6) 53 (55) US 35 Depression CDI Child June 2019 May 2020
Anxiety MASC
Operto et al,78 2022 383 383 9.9 (4.4) 150 (39) Italy NR Depression CBCL Parent 2018 March 2020
Anxiety
Rau et al,79 2021 777 777 12.9 (2.0) 414 (53) Germany NR Depression RCADS Child January 2020 June 2020
Anxiety
Rogers et al,80 2021 407 407 15.4 (1.2) 203 (50) US 48 Depression CDI-S Child October 2019 April 2020
Anxiety GAD-7
Royuela-Colomer et al,81 2022 383 383 15.6 (1.3) 222 (58) Spain NR Depression DASS-21 Child October 2019 October 2020
Anxiety
Sadeghi et al,82 2022 166 166 16.4 (11.0-17.0)b 109 (59) US 34 Depression MFQ Child March 2019 March 2020
Anxiety SCARED
Schwartz-Mette et al,83 2022 362 362 15.0 (1.1) 203 (63) US 18 Depression CESDR-10 Child January 2020 June 2020
Sequeira et al,84 2021 92 92 15.1 (1.2) 93 (100) US 28 Depression MFQ Child April 2016 April 2020
Shi et al,85 2021 7958 7958 12.0 (2.3) 3850 (48) China NA Depression CES-D Child December 2019 June 2020
Anxiety SCARED
Shoshani et al,86 2022 1537 1537 14.0 (2.0) 799 (52) Israel NR Depression BSI-18 Child September 2019 May 2020
Anxiety
Szentpetery et al,87 2021 20 20 12.0-17.0c NR US NR Depression PHQ-9 Child 2020 2021
Anxiety GAD-7
Szentpetery et al,88 2021 26 26 12.0-17.0c NR US NR Depression PHQ-9 Child 2019 2020
Anxiety GAD-7
Teng et al,89 2021 1778 1778 NR 877 (49) China NA Depression CES-D Child October to November 2019 April to May 2020
Anxiety STAI
Walters et al,90 2021 170 170 12.4 (1.0) 87 (51) US 56 Depression CES-D Child November 2019 November 2020
Wang et al,91 2022 1831 1790 13.6 (1.5) 963 (49) China NA Depression CES-D Child October 2019 October 2020
Anxiety GAD-7
Wu et al,92 2021 1627 1627 12.7 (0.6) 758 (47) China NA Depression MMHI-60 Child October 2019 May 2020
Anxiety
Yang et al,93 2022 1125 1125 14.3 (0.7) 576 (51) China NA Depression CES-DC Child November 2019 August 2020

Abbreviations: BAI, Beck Anxiety Inventory; BASC-2, Behavior Assessment System for Children, 2nd Edition; BASC-3, Behavior Assessment System for Children, 3rd Edition; BDI-2, Beck Depression Inventory, 2nd Edition; BSI-18, Brief Symptom Inventory 18; CASI, Child and Adolescent Symptom Inventory; CBCL, Child Behavior Checklist; CDI, Children’s Depression Inventory; CDI-2, Children’s Depression Inventory, 2nd Edition; CDI-S, Children’s Depression Inventory, Short Version; CES-D, Centre for Epidemiological Studies Depression Scale; CES-DC, Centre for Epidemiological Studies Depression Scale for Children; CESDR-10, 10-Item Centre for Epidemiological Studies Depression Scale–Revised; DASS-21, Depression, Anxiety and Stress Scale, 21 items; GAD-7, Generalized Anxiety Disorder Scale 7; GEAS, Global Early Adolescent Study; HSCL-25, Hopkins Symptoms Checklist-25; MASC, Multidimensional Anxiety Scale for Children; MASC-2, Multidimensional Anxiety Scale for Children, second Edition; MASQ, Mood and Anxiety Symptom Questionnaire; MFQ, Mood and Feelings Questionnaire; MMHI-60, Mental Health Inventory of Middle School Students Tool; NA, not applicable; NR, not reported; PHQ-9, Patient Health Questionnaire-9; PHQ-A, Patient Health Questionnaire for Adolescents; PROMIS, Patient-reported Outcomes Measurement Information System; RCADS, Revised Children’s Anxiety and Depression Scale; SCARED, Screen for Child Anxiety-Related Disorders; SCAS-C, Spence Children’s Anxiety Scale; SENA, System of Evaluation of Children and Adolescents; SMFQ-C, Short Mood and Feelings Questionnaire, child version; STAI, State-Trait Anxiety Inventory; STDS, State-Trait Depression Scales; YSR ASEBA, Youth Self-Report Achenbach System of Empirically Based Assessment; ZSRAS, Zung Self-Rating Anxiety Scale.

a

Racial and ethnic minoritized group was defined as individuals in the sample who were not White in a country where the majority of the population is White. This was included as a moderator because persons in racial and ethnic minoritized groups are known to be at greater risk of mental distress.

b

Age reported as mean (range).

c

Age reported as range.

Changes in Depression Symptoms

The forest plot of study estimates of changes in depression symptoms is displayed in Figure 1. There was strong evidence of an increase in depression symptoms (SMC, 0.26; 95% CI, 0.19-0.33; slight to small magnitude). Between-study heterogeneity was small (τ, 0.23; 95% CI, 0.16-0.28). Six statistical outliers were identified; however, removal of outliers did not alter the direction or magnitude of the SMC in depression symptoms. Minimal publication bias was evident.

Figure 1. Forest Plot of Changes in Depression Symptoms Among Children and Adolescents Surveyed Before and During the COVID-19 Pandemic.

Figure 1.

Data represent standardized mean changes (SMC). Error bars represent 95% CIs. Gray area represents slight changes (ie, ±0.2 standardized units). The blue diamond represents the overall mean change and corresponding 95% CI.

Moderation of Changes in Depression Symptoms

Moderators of changes in depression symptoms are displayed in Table 2. Probabilities representing the level of evidence for substantial negative, slight, and substantial positive changes in depression symptoms are displayed in eTable 5 in Supplement 1. There was good evidence that depression symptoms increased among female individuals (SMC, 0.32; 95% CI, 0.21 to 0.42; small magnitude) and slightly increased among male individuals. There was good evidence that changes in depression symptoms differed slightly between children and adolescents (depression symptoms increased in study estimates of children and adolescents by a slight to small magnitude). There was some evidence that changes in depression symptoms were larger for study estimates with mid to high income, with good evidence of an increase for study estimates drawn from individuals from a more affluent background (SMC, 0.35; 95% CI, 0.07 to 0.63; slight to moderate in magnitude). There was very good evidence of an increase in depression symptoms among study estimates from Europe (k = 10; SMC, 0.35; 95% CI, 0.17 to 0.53; slight to small magnitude) and good evidence of an increase among study estimates from North America (k = 26; SMC, 0.25; 95% CI, 0.15 to 0.36; slight to small magnitude). There was good evidence of a slight change in study estimates from Asia (k = 10). There was good evidence that changes in depression symptoms differed slightly between study estimates with lower (14%) and higher (44%) proportions of study individuals from racial and ethnic minoritized groups. There was good evidence that changes in depression symptoms differed slightly between study estimates with lower and higher baseline values for depression (SMC, −0.12; 95% CI, −0.27 to 0.04). There was very good evidence that changes in depression symptoms differed slightly between higher- and lower-quality studies.

Table 2. Variables Associated With Changes in Depressive Symptoms Among Children and Adolescents Comparing Measurements Taken Before vs During the COVID-19 Pandemic.

Variable SMC (95% CI) Magnitudea
Categorical moderators
Sex (n = 51)
Female 0.32 (0.21 to 0.42) Smallb
Male 0.10 (−0.02 to 0.22) Slight to small
Difference (female – male) 0.22 (0.06 to 0.38) Slight to smallb
Age group (n = 50)
Children (<12 y) 0.21 (0.03 to 0.39) Slight to smallb
Adolescents (≥12 y) 0.27 (0.19 to 0.34) Slight to smallb
Difference (adolescents – children) 0.05 (−0.16 to 0.26) Slight to small
Income (n = 17)
Low 0.18 (−0.06 to 0.41) Slight to smallb
Mid to high 0.35 (0.07 to 0.63) Slight to moderateb
Difference (Mid to high – low) 0.17 (−0.17 to 0.51) Slight to smallb
Region (n = 50)
North America 0.25 (0.15 to 0.36) Slight to smallb
Asia 0.11 (−0.05 to 0.27) Slight to small
Europe 0.35 (0.17 to 0.53) Slight to smallb
Continuous moderators
Baseline depressive symptoms (n = 50) −0.12 (−0.27 to 0.04) Small to slight
Study qualityc (n = 50) −0.03 (−0.18 to 0.12) Slight
Racial and ethnic minoritized groupd (n = 21) −0.01 (−0.23 to 0.21) Small to slighte

Abbreviation: SMC, standardized mean change.23

a

Magnitude thresholds for interpreting the confidence limits of SMCs were <0.2, slight; 0.2 to 0.6, small; 0.6 to 1.2, moderate; >1.2, large.39,44

b

For these magnitudes, there was at least some evidence of a substantial increase (ie, where the chances of a substantial increase in magnitude and the chances of there being a slight change in magnitude were greater than 25% and less than 95%, respectively).

c

All studies meeting full inclusion criteria were scored 1 (criterion met) or 0 (criterion unmet) for 10 criteria and summed to a score between 0 and 10 with higher scores indicating better study quality.

d

Racial and ethnic minoritized group was defined as individuals in the sample who were not White in a country where the majority of the population is White. This was included as a moderator because persons in racial and ethnic minoritized groups are known to be at greater risk of mental distress.

e

Despite the 95% CI crossing thresholds for small negative and small positive magnitudes (ie, SMC ±0.20), there was still good evidence (93% probability) that the magnitude in question was only slight.

Changes in Anxiety Symptoms

Inspection of the scatterplot of the random-effect solution vs the SE of each study estimate revealed evidence of considerable publication bias, which was addressed by excluding 3 statistical outliers and 4 study estimates with an SE greater than 0.3 (eFigure 2 in Supplement 1). The forest plot of study estimates included in the meta-analysis of changes in anxiety symptoms is displayed in Figure 2. There was good evidence that anxiety symptoms increased slightly (SMC, 0.10; 95% CI, 0.04 to 0.16). Between-study heterogeneity was slight to small in magnitude (τ, 0.13; 95% CI, 0.02 to 0.19).

Figure 2. Forest Plot of Changes in Anxiety Symptoms Among Children and Adolescents Surveyed Before and During the COVID-19 Pandemic.

Figure 2.

Data represent standardized mean changes (SMC). Error bars represent 95% CIs. Gray area represents slight changes (ie, ±0.2 standardized units). The blue diamond represents the overall mean change and corresponding 95% CI.

Moderation of Changes in Anxiety Symptoms

Moderators of changes in anxiety symptoms are displayed in Table 3. Probabilities representing the level of evidence for substantial negative, slight, and substantial positive changes in anxiety symptoms are displayed in eTable 6 in Supplement 1. There was good evidence that changes in anxiety symptoms differed slightly between female (SMC, 0.12; 95% CI, −0.03 to 0.27) and male (SMC, 0.04; 95% CI, −0.12 to 0.21) individuals, and modest evidence of a difference between children (SMC, −0.02; 95% CI, −0.21 to 0.17) and adolescents (SMC, 0.16; 95% CI, 0.07 to 0.25). There was some evidence that anxiety symptoms increased in study estimates with mid to high income (SMC, 0.14; 95% CI, −0.13 to 0.41; slight to small magnitude). There was good evidence that changes in anxiety symptoms differed slightly between study estimates with lower (12%) and higher (40%) proportions of study individuals from racial and ethnic minoritized groups (SMC, 0.06; 95% CI, −0.15 to 0.27). There was very good evidence that changes in anxiety symptoms differed slightly between study estimates with lower and higher baseline values for anxiety. There was also good evidence that changes in anxiety symptoms differed slightly between higher- and lower-quality studies (SMC −0.08; 95% CI, −0.23 to 0.07), and between study estimates from different geographical regions (North America: SMC, 0.10; 95% CI, 0.002 to 0.20; Asia: SMC, 0.06; 95% CI, −0.11 to 0.24; Europe: SMC, 0.10; 95% CI, −0.03 to 0.23).

Table 3. Moderators of Changes in Anxiety Symptoms Among Children and Adolescents Comparing Measurements Taken Before vs During the COVID-19 Pandemic.

Variable SMC (95% CI) Magnitudea
Categorical moderators
Sex (n = 36)
Female 0.12 (−0.03 to 0.27) Slight to small
Male 0.04 (−0.12 to 0.21) Slight to small
Difference (female – male) 0.08 (−0.13 to 0.29) Slight to small
Age group (n = 32)
Children (<12 y) −0.02 (−0.21 to 0.17) Small to slight
Adolescents (≥12 y) 0.16 (0.07 to 0.25) Slight to small
Difference (adolescents – children) 0.18 (−0.03 to 0.39) Slight to smallb
Income (n = 15)
Low 0.03 (−0.18 to 0.24) Slight to small
Mid to high 0.14 (−0.13 to 0.41) Slight to smallb
Difference (mid to high – low) 0.11 (−0.09 to 0.31) Slight to small
Region (n = 31)
North America 0.10 (0.002 to 0.20) Slight to small
Asia 0.06 (−0.11 to 0.24) Slight to small
Europe 0.10 (−0.03 to 0.23) Slight to small
Continuous moderators
Baseline anxiety symptoms (n = 31) 0.07 (−0.07 to 0.20) Slight to small
Study qualityc (n = 31) −0.08 (−0.23 to 0.07) Slight to small
Racial and ethnic minoritized group (n = 15) 0.06 (−0.15 to 0.27) Slight to small

Abbreviation: SMC, standardized mean change.

a

Magnitude thresholds for interpreting the confidence limits of SMCs were: <0.2, slight; 0.2 to 0.6, small; 0.6 to 1.2, moderate; >1.2, large.39,44

b

For these magnitudes, there was at least some evidence of a substantial increase (ie, where the chances of a substantial increase in magnitude and the chances of there being a slight change in magnitude were greater than 25% and less than 95%, respectively).23

c

All studies meeting full inclusion criteria were scored 1 (criterion met) or 0 (criterion unmet) for 10 criteria and summed to a score between 0 and 10 with higher scores indicating better study quality.

Discussion

This systematic review and meta-analysis included 53 studies with 87 study estimates (49 for depression symptoms; 38 for anxiety symptoms) representing 40 807 children and adolescents across 12 countries. Contrary to a meta-analysis of 8 studies showing minimal change in depression symptoms in youth aged 10 to 19 years,5 our comprehensive systematic review and meta-analysis of child and adolescents samples showed that there was evidence of an increase in depression symptoms during the COVID-19 pandemic compared to prepandemic estimates. The magnitude of this increase was more than what could be expected based on time trends94 and can therefore likely be attributed to the disruptions, restrictions, and stress imposed on children and adolescents and their families during the pandemic.6,7,8,11,15,17,18,95 Anxiety symptoms increased slightly during the pandemic. Such differences between changes in depression and anxiety symptoms are consistent with research highlighting COVID-19–related impacts on social isolation and activity restrictions on children’s sadness, sense of purpose, and hopelessness,96,97,98 which mostly perpetuate depressed mood. Moreover, there tends to be greater reactivity and episodicity of mood, whereas anxiety has greater intraindividual stability over time.99

Our findings suggest increases occurred equally for samples of children and adolescents displaying clinical, threshold, subthreshold, and even low levels of depression symptoms before the pandemic. The widespread nature of the disruptions caused by the pandemic impacted samples across the full spectrum of mental health symptomatology (relative to their baseline value for mood). These findings are consistent with sensitizing effects in 2 ways. First, those who were experiencing depression before the pandemic may have had difficulty coping when faced with additional stressors; second, those with less experience with stress may have had difficulty coping with new unfamiliar and accumulating stressors.100 Thus, children and adolescents who did not previously seek or need mental health support potentially needed such support during the pandemic. When children and adolescents experience mental distress without access to evidenced-based interventions, their risk of relapse prior to age 17 years is 7 times higher than children and adolescents who receive treatment services.101 Thus, to match the potential increase in demand across the spectrum of mental health, increased resource allocation and provision of mental health services are needed to address the mental health system burden.

Consistent with prior research,1,16,102 increases in depression in this systematic review and meta-analysis were greater among samples of female individuals vs samples of male individuals. In general, depression and anxiety are twice as common in female youth compared to male youth103; this sex difference appears to arise after puberty104 and persists across the lifecourse.105 Potential explanations for the sex difference in COVID-19 pandemic–related changes in depression include a greater propensity to ruminate,106 higher reported rates of loneliness,107 and increased exposure to adversity and violence108 as well as social media use among female young people compared to their male counterparts.107 In contrast, male youth are more likely to exhibit externalizing symptoms (eg, aggression and violence),109 and as such, consideration of internalizing (ie, depression and anxiety) symptoms in isolation may underestimate the magnitude of mental distress and pandemic-related behavioral change among boys. Future research examining internalizing and externalizing symptoms in tandem is needed to gain a more comprehensive perspective on sex differences.

We found some evidence that changes in depression and anxiety symptoms during the COVID-19 pandemic were larger for samples drawn from higher income backgrounds. This finding could be related to greater accessibility to digital devices,110 given the increased use of digital devices during the pandemic6 and their known association with depression.111,112 It is also possible that children and adolescents from higher income backgrounds had more violated expectations and routine disruptions (eg, the cancellation of extracurricular activities, such as music lessons and sports clubs) during the pandemic due to their more frequent engagement with extracurricular activities.

Our findings are in line with other mental health–related studies which report increases in eating disorders113,114 and emergency department visits for suicide attempts and ideation during the COVID-19 pandemic.115 Accordingly, countries should continue to prioritize nationally representative longitudinal studies on child and adolescent mental health. A nimble approach requires a strategy that includes the monitoring of the entire population so that a comprehensive understanding of individual variations in risk is afforded, and in turn, the appropriate allocation of services to those most in need, now and in the future.116

The burden of mental illness experienced at any point in the life course is considerable. Child and adolescent mental illness is associated with poor personal outcomes, such as impaired cognition, academic performance, quality of life, interpersonal functioning, employment, and physical health,117,118 and presents a considerable risk for experiencing later psychopathology.119,120,121 For example, adolescents with persistently high social anxiety are 13 times more likely to meet diagnostic criteria for generalized anxiety disorders and 20 times more likely to be diagnosed with depression in adulthood compared to adolescents with low social anxiety symptoms.122 Such continuity between early and later life psychopathology is striking given that mental health problems are leading causes of disability and disease worldwide.94,123 Furthermore, if sustained into adulthood, mental illness can disrupt financial support and stability for individuals and families. More broadly, mental health disability leads to an approximate 4% in losses in high-income countries124 in gross domestic product annually.125,126

Limitations

This study has limitations. First, our findings should be further verified with studies that incorporate diagnostic interviews. Second, while we included studies from 7 non–native English-speaking countries and 2 bilingual countries, language limits to studies published in English may limit the generalizability of our findings. Third, there was only 1 study estimate54 of COVID-19–related changes in mental health outcomes among gender-diverse children and adolescents. This represents a potential limitation because gender-diverse children and adolescents bear a disproportionate burden of mental health symptoms.127,128,129 Fourth, this synthesis can only speak to population-based samples of children and adolescents. Fifth, most studies included in this systematic review and meta-analysis collected data on child and adolescent mental health within the first year of the pandemic.

Conclusions

Results from this systematic review and meta-analysis of longitudinal cohorts suggest that the widespread uncertainty, at times severe restrictions, and repeated disruptions during the pandemic might have pushed some youth, especially female individuals and adolescents, beyond their typical stress threshold. Our results, as well as those of many other scholars, sound a clarion call to policy makers that a response is needed to directly address the mental health crisis being experienced by children and adolescents. The development and widespread availability of timely and evidence-based global mental health prevention and intervention efforts to address childhood mental illness are critical and urgently needed.

Supplement 1.

eTable 1. Search strategy from Ovid MEDLINE

eTable 2. Quality assessment criteria

eTable 3. Quality assessment scores of included studies

eTable 4. Assessment of sampling uncertainty

eTable 5. Assessment of sampling uncertainty in estimates of change and moderators of change in depression symptoms among children and adolescents comparing measurements taken before to during the COVID-19 pandemic

eTable 6. Assessment of sampling uncertainty in estimates of change and moderators of change in anxiety symptoms among children and adolescents comparing measurements taken before to during the COVID-19 pandemic

eFigure 1. Study selection

eFigure 2. Scatterplots of the random effect solution versus the study estimate standard error before (left) and after (right) elimination of statistical outliers and study-estimates representing publication bias

eReferences

Supplement 2.

Data sharing statement

References

  • 1.Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021;175(11):1142-1150. doi: 10.1001/jamapediatrics.2021.2482 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pierce M, McManus S, Jessop C, et al. Says who? the significance of sampling in mental health surveys during COVID-19. Lancet Psychiatry. 2020;7(7):567-568. doi: 10.1016/S2215-0366(20)30237-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Robinson E, Sutin AR, Daly M, Jones A. A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in 2020. J Affect Disord. 2022;296:567-576. doi: 10.1016/j.jad.2021.09.098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bussières E-L, Malboeuf-Hurtubise C, Meilleur A, et al. Consequences of the COVID-19 pandemic on children’s mental health: a meta-analysis. Frontiers in Psychiatry . 2021;12:2125. doi: 10.3389/fpsyt.2021.691659 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sun Y, Wu Y, Fan S, et al. Comparison of mental health symptoms before and during the COVID-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts. BMJ . 2023;380:e074224. doi: 10.1136/bmj-2022-074224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Madigan S, Eirich R, Pador P, McArthur BA, Neville RD. Assessment of changes in child and adolescent screen time during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(12):1188-1198. doi: 10.1001/jamapediatrics.2022.4116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.McArthur BA, Racine N, McDonald S, Tough S, Madigan S. Child and family factors associated with child mental health and well-being during COVID-19. Eur Child Adolesc Psychiatry. 2023;32(2):223-233. doi: 10.1007/s00787-021-01849-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tsujimoto KC, Cost KT, LaForge-MacKenzie K, et al. School and learning contexts during the COVID-19 pandemic: implications for child and youth mental health. Curr Psychol. 2022;1-17. doi: 10.1007/s12144-022-03941-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Farrell AH, Vitoroulis I, Eriksson M, Vaillancourt T. Loneliness and well-being in children and adolescents during the COVID-19 pandemic: a systematic review. Children (Basel). 2023;10(2):279. doi: 10.3390/children10020279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Neville RD, Lakes KD, Hopkins WG, et al. Global changes in child and adolescent physical activity during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(9):886-894. doi: 10.1001/jamapediatrics.2022.2313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Health. 2020;4(6):421. doi: 10.1016/S2352-4642(20)30109-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Goodman SH, Gotlib IH. Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev. 1999;106(3):458-490. doi: 10.1037/0033-295X.106.3.458 [DOI] [PubMed] [Google Scholar]
  • 14.Hentges RF, Graham SA, Fearon P, Tough S, Madigan S. The chronicity and timing of prenatal and antenatal maternal depression and anxiety on child outcomes at age 5. Depress Anxiety. 2020;37(6):576-586. doi: 10.1002/da.23039 [DOI] [PubMed] [Google Scholar]
  • 15.Racine N, Hetherington E, McArthur BA, et al. Maternal depressive and anxiety symptoms before and during the COVID-19 pandemic in Canada: a longitudinal analysis. Lancet Psychiatry. 2021;8(5):405-415. doi: 10.1016/S2215-0366(21)00074-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pierce M, Hope H, Ford T, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatry. 2020;7(10):883-892. doi: 10.1016/S2215-0366(20)30308-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Letourneau N, Luis MA, Kurbatfinski S, et al. COVID-19 and family violence: a rapid review of literature published up to 1 year after the pandemic declaration. EClinicalMedicine. 2022;53:101634. doi: 10.1016/j.eclinm.2022.101634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Canadian Centre on Substance Abuse and Addiction . 25% of Canadians (aged 35-54) are drinking more while at home due to COVID-19 pandemic; cite lack of regular schedule, stress and boredom as main factors. Accessed January 27, 2023. https://www.ccsa.ca/sites/default/files/2020-04/CCSA-NANOS-Alcohol-Consumption-During-COVID-19-Report-2020-en.pdf
  • 19.Hollenstein T, Colasante T, Lougheed JP. Adolescent and maternal anxiety symptoms decreased but depressive symptoms increased before to during COVID-19 lockdown. J Res Adolesc. 2021;31(3):517-530. doi: 10.1111/jora.12663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Li M, Yu C, Zuo X, et al. COVID-19 experiences and health-related implications: results from a mixed-method longitudinal study of urban poor adolescents in Shanghai. J Adolesc Health . 2022;71(1):30-38. doi: 10.1016/j.jadohealth.2022.03.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ertanir B, Kassis W, Garrote A. Longitudinal changes in Swiss adolescent’s mental health outcomes from before and during the COVID-19 pandemic. Int J Environ Res Public Health. 2021;18(23):12734. doi: 10.3390/ijerph182312734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Breaux R, Dvorsky MR, Marsh NP, et al. Prospective impact of COVID-19 on mental health functioning in adolescents with and without ADHD: protective role of emotion regulation abilities. J Child Psychol Psychiatry. 2021;62(9):1132-1139. doi: 10.1111/jcpp.13382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Adegboye D, Williams F, Collishaw S, et al. Understanding why the COVID-19 pandemic-related lockdown increases mental health difficulties in vulnerable young children. JCPP Adv. 2021;1(1):e12005. doi: 10.1111/jcv2.12005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bignardi G, Dalmaijer ES, Anwyl-Irvine AL, et al. Longitudinal increases in childhood depression symptoms during the COVID-19 lockdown. Arch Dis Child. 2020;106(8):791-797. doi: 10.1136/archdischild-2020-320372 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hite A, Lim Y, Abdallah M, Hu W, Nakamura C, Suddath R. 34.3 Impacts of socioeconomic status and the COVID-19 pandemic on symptoms of child and adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. 2021;60(10):S217. doi: 10.1016/j.jaac.2021.09.273 [DOI] [Google Scholar]
  • 26.Siddaway AP, Wood AM, Hedges LV. How to do a systematic review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses. Annu Rev Psychol. 2019;70:747-770. doi: 10.1146/annurev-psych-010418-102803 [DOI] [PubMed] [Google Scholar]
  • 27.Ridout KK, Alavi M, Ridout SJ, et al. Emergency department encounters among youth with suicidal thoughts or behaviors during the COVID-19 pandemic. JAMA Psychiatry. 2021;78(12):1319-1328. doi: 10.1001/jamapsychiatry.2021.2457 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mayne SL, Hannan C, Davis M, et al. COVID-19 and adolescent depression and suicide risk screening outcomes. Pediatrics. 2021;148(3):e2021051507. doi: 10.1542/peds.2021-051507 [DOI] [PubMed] [Google Scholar]
  • 29.Beaudry G, Drouin O, Gravel J, et al. A comparative analysis of pediatric mental health-related emergency department utilization in Montréal, Canada, before and during the COVID-19 pandemic. Ann Gen Psychiatry. 2022;21(1):17. doi: 10.1186/s12991-022-00398-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Nock MK, Green JG, Hwang I, et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry. 2013;70(3):300-310. doi: 10.1001/2013.jamapsychiatry.55 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.McKnight-Eily LR, Okoro CA, Strine TW, et al. Racial and ethnic disparities in the prevalence of stress and worry, mental health conditions, and increased substance use among adults during the COVID-19 pandemic—United States, April and May 2020. MMWR Morb Mortal Wkly Rep. 2021;70(5):162-166. doi: 10.15585/mmwr.mm7005a3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kapilashrami A, Bhui K. Mental health and COVID-19: is the virus racist? Br J Psychiatry. 2020;217(2):405-407. doi: 10.1192/bjp.2020.93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kalb LG, Stapp EK, Ballard ED, Holingue C, Keefer A, Riley A. Trends in psychiatric emergency department visits among youth and young adults in the US. Pediatrics. 2019;143(4):e20182192. doi: 10.1542/peds.2018-2192 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Newton AS, Rosychuk RJ, Dong K, Curran J, Slomp M, McGrath PJ. Emergency health care use and follow-up among sociodemographic groups of children who visit emergency departments for mental health crises. CMAJ. 2012;184(12):E665-E674. doi: 10.1503/cmaj.111697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Yildiz M, Demirhan E, Gurbuz S. Contextual socioeconomic disadvantage and adolescent suicide attempts: a multilevel investigation. J Youth Adolesc. 2019;48(4):802-814. doi: 10.1007/s10964-018-0961-z [DOI] [PubMed] [Google Scholar]
  • 36.Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71):n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.National Heart, Lung, and Blood Institute . Quality assessment tool for observational cohort and cross-sectional studies. Accessed October 1, 2022. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
  • 39.Cohen J. Statistical power analysis for the behavioral sciences. Routledge; 2013. doi: 10.4324/9780203771587 [DOI] [Google Scholar]
  • 40.Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library; 2008. https://training.cochrane.org/handbook [Google Scholar]
  • 41.Yang M. A Review of Random Effects Modelling in SAS (Release 8.2). Centre for Multilevel Modelling; 2003. [Google Scholar]
  • 42.Higgins JPT. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158-1160. doi: 10.1093/ije/dyn204 [DOI] [PubMed] [Google Scholar]
  • 43.Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009;41(1):3-13. doi: 10.1249/MSS.0b013e31818cb278 [DOI] [PubMed] [Google Scholar]
  • 44.Cumming G. The new statistics: why and how. Psychol Sci. 2014;25(1):7-29. doi: 10.1177/0956797613504966 [DOI] [PubMed] [Google Scholar]
  • 45.Rothman KJ. Epidemiology: An Introduction. Oxford University Press; 2012. [Google Scholar]
  • 46.Hopkins WG. Replacing statistical significance and non-significance with better approaches to sampling uncertainty. Frontiers in Physiology . 2022;13:962132. doi: 10.3389/fphys.2022.962132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Alt P, Reim J, Walper S. Fall from grace: increased loneliness and depressiveness among extraverted youth during the German COVID-19 lockdown. J Res Adolesc . 2021;31(3):678-691. doi: 10.1111/jora.12648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bano M, Anton CM, Butts R, Triplett K. Worsening mental health in adolescent heart failure and transplant patients during the COVID-19 pandemic. J Heart Lung Transplant. 2022;41(4):S503-S504. doi: 10.1016/j.healun.2022.01.1277 [DOI] [Google Scholar]
  • 49.Bélanger RE, Patte KA, Leatherdale ST, Gansaonré RJ, Haddad S. An impact analysis of the early months of the COVID-19 pandemic on mental health in a prospective cohort of Canadian adolescents. J Adolesc Health. 2021;69(6):917-924. doi: 10.1016/j.jadohealth.2021.07.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Bouter DC, Zarchev M, de Neve-Enthoven NGM, et al. A longitudinal study of mental health in at-risk adolescents before and during the COVID-19 pandemic. Eur Child Adolesc Psychiatry. 2022;1-9. doi: 10.1007/s00787-021-01935-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Caha D. The relationship between internalizing psychopathology and poor sleep: stability and the influence of the COVID-19 pandemic and stress in youth and adult women. Diss Abstr Int . 2022;83(3-B). https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1651809 [Google Scholar]
  • 52.Cantiani C, Dondena C, Capelli E, Riboldi EM, Molteni M, Riva V. Effects of COVID-19 lockdown on the emotional and behavioral profiles of preschool Italian children with and without familial risk for neurodevelopmental disorders. Brain Sci . 2021;11(4):477. doi: 10.3390/brainsci11040477 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Charmaraman L, Lynch AD, Richer AM, Zhai E. Examining early adolescent positive and negative social technology behaviors and well-being during the COVID-19 pandemic. Technol Mind Behav. 2022;3(1). doi: 10.1037/tmb0000062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Chavarria M, Abdallah M, Hu W, et al. 38.6 Impact of gender identity and the COVID-19 pandemic on child and adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. 2021;60(10)(suppl):S226-S227. doi: 10.1016/j.jaac.2021.09.303 [DOI] [Google Scholar]
  • 55.Chen CY, Chen IH, Hou WL, et al. The relationship between children’s problematic internet-related behaviors and psychological distress during the onset of the COVID-19 pandemic: a longitudinal study. J Addict Med. 2022;16(2):e73-e80. doi: 10.1097/ADM.0000000000000845 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Cohen ZP, Cosgrove KT, DeVille DC, et al. The impact of COVID-19 on adolescent mental health: preliminary findings from a longitudinal sample of healthy and at-risk adolescents. Front Pediatr . 2021;9:622608. doi: 10.3389/fped.2021.622608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.De France K, Hancock GR, Stack DM, Serbin LA, Hollenstein T. The mental health implications of COVID-19 for adolescents: follow-up of a four-wave longitudinal study during the pandemic. Am Psychol. 2022;77(1):85-99. doi: 10.1037/amp0000838 [DOI] [PubMed] [Google Scholar]
  • 58.Duttweiler HR, Sheena MK, Burkhouse KL, Feurer C. The effects of rumination on internalising symptoms in the context of the COVID-19 pandemic among mothers and their offspring: a brief report. Cogn Emot. 2022;36(1):92-99. doi: 10.1080/02699931.2021.1995330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ertanir B, Kassis W, Garrote A. Longitudinal changes in swiss adolescent's mental health outcomes from before and during the covid-19 pandemic. Int J Environ Res Public Health. 2021;18(23):12734. doi: 10.3390/ijerph182312734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Feurer C, Granros M, Calentino AE, Suor JH, Burkhouse KL. Risk for youth anxiety during the COVID-19 pandemic: the interactive impact of financial stress and prepandemic electrocortical reactivity to negative self-referential stimuli. Dev Psychobiol. 2022;64(3):e22250. doi: 10.1002/dev.22250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Gadassi Polack R, Sened H, Aubé S, Zhang A, Joormann J, Kober H. Connections during crisis: adolescents’ social dynamics and mental health during COVID-19. Dev Psychol. 2021;57(10):1633-1647. doi: 10.1037/dev0001211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Giménez-Dasí M, Quintanilla L, Lucas-Molina B, Sarmento-Henrique R. Six weeks of confinement: psychological effects on a sample of children in early childhood and primary education. Front Psychol. 2020;11:590463. doi: 10.3389/fpsyg.2020.590463 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Giménez-Dasí M, Quintanilla L, Fernandez-Sanchez M. Longitudinal effects of the pandemic and confinement on the anxiety levels of a sample of Spanish children in primary education. Int J Environ Res Public Health. 2021;18(24):13063. doi: 10.3390/ijerph182413063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Gladstone TRG, Schwartz JAJ, Possel P, Richer AM, Buchholz KR, Rintell LS. Depressive symptoms among adolescents: testing vulnerability-stress and protective models in the context of COVID-19. Child Psychiatry Hum Dev. 2022;53(6):1372-1382. doi: 10.1007/s10578-021-01216-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Hawes MT, Szenczy AK, Klein DN, Hajcak G, Nelson BD. Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic. Psychol Med. 2022;52(14):3222-3230. doi: 10.1017/S0033291720005358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.He Y, Chen S-S, Xie G-D, et al. Bidirectional associations among school bullying, depressive symptoms and sleep problems in adolescents: a cross-lagged longitudinal approach. J Affect Disord. 2022;298(Pt A):590-598. doi: 10.1016/j.jad.2021.11.038 [DOI] [PubMed] [Google Scholar]
  • 67.Hollenstein T, Colasante T, Lougheed JP. Adolescent and maternal anxiety symptoms decreased but depressive symptoms increased before to during COVID-19 lockdown. J Res Adolesc. 2021;31(3):517-530. doi: 10.1111/jora.12663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Houghton S, Kyron M, Hunter SC, et al. Adolescents’ longitudinal trajectories of mental health and loneliness: the impact of COVID-19 school closures. J Adolesc. 2022;94(2):191-205. doi: 10.1002/jad.12017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Huang KX, Oberoi MK, Hu VJ, et al. Psychosocial functioning of children with craniofacial anomalies before and during COVID-19. J Am Coll Surg. 2021;233(5)(suppl 2):e163-e164. doi: 10.1016/j.jamcollsurg.2021.08.441 [DOI] [Google Scholar]
  • 70.Janssen LHC, Kullberg MJ, Verkuil B, et al. Does the COVID-19 pandemic impact parents’ and adolescents’ well-being? an EMA-study on daily affect and parenting. PLoS One. 2020;15(10):e0240962. doi: 10.1371/journal.pone.0240962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Kwok S, Engle J, Datta AN. Resilience of adolescents and teenagers with self-limited and genetic-generalized epilepsy during the COVID-19 pandemic. Epilepsy Behav Rep. 2022;17:100520. doi: 10.1016/j.ebr.2021.100520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Li Y, Zhou Y, Ru T, Niu J, He M, Zhou G. How does the COVID-19 affect mental health and sleep among Chinese adolescents: a longitudinal follow-up study. Sleep Med. 2021;85:246-258. doi: 10.1016/j.sleep.2021.07.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Liao S, Luo B, Liu H, et al. Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic. Sleep Med. 2021;84:289-293. doi: 10.1016/j.sleep.2021.06.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Liu SR, Davis EP, Palma AM, Sandman CA, Glynn LM. The acute and persisting impact of COVID-19 on trajectories of adolescent depression: sex differences and social connectedness. J Affect Disord. 2022;299:246-255. doi: 10.1016/j.jad.2021.11.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Magson NR, Freeman JYA, Rapee RM, Richardson CE, Oar EL, Fardouly J. Risk and protective factors for prospective changes in adolescent mental health during the COVID-19 pandemic. J Youth Adolesc. 2021;50(1):44-57. doi: 10.1007/s10964-020-01332-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Menter K, Ritchie T, Ogg J, et al. Changes in parenting practices during the COVID-19 pandemic: child behavior and mindful parenting as moderators. School Psych Rev. 2022;51(2):132-149. doi: 10.1080/2372966X.2020.1869497 [DOI] [Google Scholar]
  • 77.Mlawer F, Moore CC, Hubbard JA, Meehan ZM. Pre-pandemic peer relations predict adolescents' internalizing response to COVID-19. Res Child Adolesc Psychopathol. 2022;50(5):649-657. doi: 10.1007/s10802-021-00882-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Operto FF, Coppola G, Vivenzio V, et al. Impact of COVID-19 pandemic on children and adolescents with neuropsychiatric disorders: emotional/behavioral symptoms and parental stress. Int J Environ Res Public Health. 2022;19(7):3795. doi: 10.3390/ijerph19073795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Rau LM, Grothus S, Sommer A, et al. Chronic Pain in Schoolchildren and its Association With Psychological Wellbeing Before and During the COVID-19 Pandemic. J Adolesc Health. 2021;69(5):721-728. doi: 10.1016/j.jadohealth.2021.07.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Rogers AA, Ha T, Ockey S. Adolescents’ perceived socio-emotional impact of COVID-19 and implications for mental health: results from a U.S.-based mixed-methods study. J Adolesc Health. 2021;68(1):43-52. doi: 10.1016/j.jadohealth.2020.09.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Royuela-Colomer E, Fernández-González L, Orue I, Calvete E. The association between exposure to COVID-19, internalizing symptoms, and dispositional mindfulness in adolescents: a longitudinal pre- and during-pandemic study. Child Psychiatry Hum Dev. 2022;1-13. doi: 10.1007/s10578-022-01349-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Sadeghi N, Fors PQ, Eisner L, et al. Mood and behaviors of adolescents with depression in a longitudinal study before and during the COVID-19 pandemic. J Am Acad Child Adolesc Psychiatry. 2022;61(11):1341-1350. doi: 10.1016/j.jaac.2022.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Schwartz-Mette RA, Duell N, Lawrence HR, Balkind EG. COVID-19 distress impacts adolescents’ depressive symptoms, NSSI, and suicide risk in the rural, Northeast US. J Clin Child Adolesc Psychol. 2022;1-14. doi: 10.1080/15374416.2022.2042697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Sequeira SL, Silk JS, Hutchinson E, Jones NP, Ladouceur CD. Neural responses to social reward predict depressive symptoms in adolescent girls during the COVID-19 pandemic. J Pediatr Psychol. 2021;46(8):915-926. doi: 10.1093/jpepsy/jsab037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Shi W, Yuan GF, Hall BJ, et al. Mental disorders and emotional competence among Chinese adolescents before and during COVID-19 pandemic: a longitudinal mediation model. Front Public Health. 2021;9:767004. doi: 10.3389/fpubh.2021.767004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Shoshani A, Kor A. The mental health effects of the COVID-19 pandemic on children and adolescents: risk and protective factors. Psychol Trauma. 2022;14(8):1365-1373. doi: 10.1037/tra0001188 [DOI] [PubMed] [Google Scholar]
  • 87.Szentpetery S, Foil K, Flume P, Christon L. Anxiety and depression screening: A five-year experience in a southeastern pediatric CF program. J Cyst Fibros. 2021;20(suppl 2):S146. doi: 10.1016/S1569-1993(21)01728-8 [DOI] [Google Scholar]
  • 88.Szentpetery S, Foil K, Christon L. The COVID-19 pandemic and trends in anxiety and depressive symptoms in adolescents with cystic fibrosis and their caregivers. J Cyst Fibros. 2021;20(suppl 2):S150-S151. doi: 10.1016/S1569-1993(21)01738-0 [DOI] [Google Scholar]
  • 89.Teng Z, Pontes HM, Nie Q, Griffiths MD, Guo C. Depression and anxiety symptoms associated with internet gaming disorder before and during the COVID-19 pandemic: a longitudinal study. J Behav Addict. 2021;10(1):169-180. doi: 10.1556/2006.2021.00016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Walters GD, Runell L, Kremser J. Social and psychological effects of the COVID-19 pandemic on middle-school students: attendance options and changes over time. Sch Psychol. 2021;36(5):277-284. doi: 10.1037/spq0000438 [DOI] [PubMed] [Google Scholar]
  • 91.Wang W, Guo Y, Du X, et al. Associations between poor sleep quality, anxiety symptoms, and depressive symptoms among Chinese adolescents before and during COVID-19: a longitudinal study. Frontiers Psychiatry. 2022;12:786640. doi: 10.3389/fpsyt.2021.786640 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Wu Z, Liu Z, Zou Z, et al. Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China. Schizophr Res. 2021;237:40-46. doi: 10.1016/j.schres.2021.08.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Yang Z, Luo Y, Zhou Q, et al. COVID-19-related stressors and depression in Chinese adolescents: the effects of life history strategies and gender. J Affect Disord. 2022;304:122-127. doi: 10.1016/j.jad.2022.02.060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Copeland WE, Wolke D, Shanahan L, Costello EJ. Adult functional outcomes of common childhood psychiatric problems: a prospective, longitudinal study. JAMA Psychiatry. 2015;72(9):892-899. doi: 10.1001/jamapsychiatry.2015.0730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Cénat JM, Farahi SMMM, Dalexis RD, et al. The global evolution of mental health problems during the COVID-19 pandemic: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2022;315:70-95. doi: 10.1016/j.jad.2022.07.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Cost KT, Crosbie J, Anagnostou E, et al. Mostly worse, occasionally better: impact of COVID-19 pandemic on the mental health of Canadian children and adolescents. Eur Child Adolesc Psychiatry. 2022;31(4):671-684. doi: 10.1007/s00787-021-01744-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Yard E, Radhakrishnan L, Ballesteros MF, et al. Emergency department visits for suspected suicide attempts among persons aged 12–25 years before and during the COVID-19 pandemic—United States, January 2019–May 2021. MMWR Morb Mortal Wkly Rep. 2021;70(24):888-894. doi: 10.15585/mmwr.mm7024e1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Widnall E, Adams EA, Plackett R, et al. Adolescent experiences of the COVID-19 pandemic and school closures and implications for mental health, peer relationships and learning: a qualitative study in South-West England. Int J Environ Res Public Health. 2022;19(12):7163. doi: 10.3390/ijerph19127163 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Prenoveau JM. Craske MG, Zinbarg RE, Mineka S, Rose RD, Griffith JW. Are anxiety and depression just as stable as personality during late adolescence? results from a three-year longitudinal latent variable study. J Abnorm Psychol. 2011;120(4):832-843. doi: 10.1037/a0023939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Wade M, Prime H, Browne DT. Why we need longitudinal mental health research with children and youth during (and after) the COVID-19 pandemic. Psychiatry Res. 2020;290:113143. doi: 10.1016/j.psychres.2020.113143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Neufeld SAS, Dunn VJ, Jones PB, Croudace TJ, Goodyer IM. Reduction in adolescent depression after contact with mental health services: a longitudinal cohort study in the UK. Lancet Psychiatry. 2017;4(2):120-127. doi: 10.1016/S2215-0366(17)30002-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Essau CA, Lewinsohn PM, Seeley JR, Sasagawa S. Gender differences in the developmental course of depression. J Affect Disord. 2010;127(1-3):185-190. doi: 10.1016/j.jad.2010.05.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Collishaw S. Annual research review: secular trends in child and adolescent mental health. J Child Psychol Psychiatry. 2015;56(3):370-393. doi: 10.1111/jcpp.12372 [DOI] [PubMed] [Google Scholar]
  • 104.Platt JM, Bates L, Jager J, McLaughlin KA, Keyes KM. Is the US gender gap in depression changing over time? a meta-regression. Am J Epidemiol. 2021;190(7):1190-1206. doi: 10.1093/aje/kwab002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Kessler RC, Berglund P, Demler O, et al. ; National Comorbidity Survey Replication . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. doi: 10.1001/jama.289.23.3095 [DOI] [PubMed] [Google Scholar]
  • 106.Hankin BL. Development of sex differences in depressive and co-occurring anxious symptoms during adolescence: descriptive trajectories and potential explanations in a multiwave prospective study. J Clin Child Adolesc Psychol. 2009;38(4):460-472. doi: 10.1080/15374410902976288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Guazzini A, Pesce A, Gino F, Duradoni M. How the COVID-19 pandemic changed adolescents’ use of technologies, sense of community, and loneliness: a retrospective perception analysis. Behav Sci (Basel). 2022;12(7):228. doi: 10.3390/bs12070228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Piccinelli M, Wilkinson G. Gender differences in depression. critical review. Br J Psychiatry. 2000;177(6):486-492. doi: 10.1192/bjp.177.6.486 [DOI] [PubMed] [Google Scholar]
  • 109.Merikangas KR, He JP, Burstein M, et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011;50(1):32-45. doi: 10.1016/j.jaac.2010.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Harris C, Straker L, Pollock C. A socioeconomic related ‘digital divide’ exists in how, not if, young people use computers. PLoS One. 2017;12(3):e0175011. doi: 10.1371/journal.pone.0175011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Eirich R, McArthur BA, Anhorn C, McGuinness C, Christakis DA, Madigan S. Association of screen time with internalizing and externalizing behavior problems in children 12 years or younger: a systematic review and meta-analysis. JAMA Psychiatry. 2022;79(5):393-405. doi: 10.1001/jamapsychiatry.2022.0155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Liu M, Wu L, Yao S. Dose-response association of screen time-based sedentary behaviour in children and adolescents and depression: a meta-analysis of observational studies. Br J Sports Med. 2016;50(20):1252-1258. doi: 10.1136/bjsports-2015-095084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Agostino H, Burstein B, Moubayed D, et al. Trends in the incidence of new-onset anorexia nervosa and atypical anorexia nervosa among youth during the COVID-19 pandemic in Canada. JAMA Netw Open. 2021;4(12):e2137395-e2137395. doi: 10.1001/jamanetworkopen.2021.37395 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Hartman-Munick SM, Lin JA, Milliren CE, et al. Association of the COVID-19 pandemic with adolescent and young adult eating disorder care volume. JAMA Pediatr. 2022;176(12):1225-1232. doi: 10.1001/jamapediatrics.2022.4346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Madigan S, Korczak DJ, Vaillancourt T, et al. Comparison of paediatric emergency department visits for attempted suicide, self-harm, and suicidal ideation before and during the COVID-19 pandemic: a systematic review and meta-analysis. Lancet Psychiatry.2023;S2215-0366(23)00036-6. doi: 10.1016/S2215-0366(23)00036-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Vaillancourt T, Szatmari P. Child development, major disruptive events—public health implications. Oxford Research Encyclopedia of Global Public Health . Published August 15, 2022. Accessed November 12, 2022. https://oxfordre.com/publichealth/display/10.1093/acrefore/9780190632366.001.0001/acrefore-9780190632366-e-159;jsessionid=A37F7AB59AAC88E736A85618876FD64A
  • 117.Scott KM, Von Korff M, Alonso J, et al. Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med. 2009;39(1):33-43. doi: 10.1017/S0033291708003188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Thapar A, Eyre O, Patel V, Brent D. Depression in young people. Lancet. 2022;400(10352):617-631. doi: 10.1016/S0140-6736(22)01012-1 [DOI] [PubMed] [Google Scholar]
  • 119.Johnson D, Dupuis G, Piche J, Clayborne Z, Colman I. Adult mental health outcomes of adolescent depression: a systematic review. Depress Anxiety. 2018;35(8):700-716. doi: 10.1002/da.22777 [DOI] [PubMed] [Google Scholar]
  • 120.Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry. 2001;49(12):1002-1014. doi: 10.1016/S0006-3223(01)01129-5 [DOI] [PubMed] [Google Scholar]
  • 121.Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry. 2003;60(7):709-717. doi: 10.1001/archpsyc.60.7.709 [DOI] [PubMed] [Google Scholar]
  • 122.Krygsman A, Vaillancourt T. Elevated social anxiety symptoms across childhood and adolescence predict adult mental disorders and cannabis use. Compr Psychiatry. 2022;115:152302. doi: 10.1016/j.comppsych.2022.152302 [DOI] [PubMed] [Google Scholar]
  • 123.Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-1586. doi: 10.1016/S0140-6736(13)61611-6 [DOI] [PubMed] [Google Scholar]
  • 124.Organization for Economic Co-operation and Development . Mental health. Accessed November 20, 2022. https://www.oecd.org/health/health-systems/mental-health.htm
  • 125.Mental Health Commission of Canada . Strengthening the Case for Investing in Canada’s Mental Health System. Accessed November 22, 2022. https://www.mentalhealthcommission.ca/English/media/4412
  • 126.Sutherland G. Healthy brains at work: estimating the impact of workplace mental health benefits and programs. The Conference Board of Canada . Accessed November 2, 2022. https://www.conferenceboard.ca/product/healthy-brains-at-work-estimating-the-impact-of-workplace-mental-health-benefits-and-programs/
  • 127.Hatchel T, Polanin JR, Espelage DL. Suicidal thoughts and behaviors among LGBTQ youth: meta-analyses and a systematic review. Arch Suicide Res. 2021;25(1):1-37. doi: 10.1080/13811118.2019.1663329 [DOI] [PubMed] [Google Scholar]
  • 128.Ormiston CK, Williams F. LGBTQ youth mental health during COVID-19: unmet needs in public health and policy. Lancet. 2022;399(10324):501-503. doi: 10.1016/S0140-6736(21)02872-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Centers for Disease Control and Prevention . Lesbian, gay, bisexual, and transgender health. Published 2023. Accessed February 26, 2023. https://www.cdc.gov/lgbthealth/youth.htm

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1.

eTable 1. Search strategy from Ovid MEDLINE

eTable 2. Quality assessment criteria

eTable 3. Quality assessment scores of included studies

eTable 4. Assessment of sampling uncertainty

eTable 5. Assessment of sampling uncertainty in estimates of change and moderators of change in depression symptoms among children and adolescents comparing measurements taken before to during the COVID-19 pandemic

eTable 6. Assessment of sampling uncertainty in estimates of change and moderators of change in anxiety symptoms among children and adolescents comparing measurements taken before to during the COVID-19 pandemic

eFigure 1. Study selection

eFigure 2. Scatterplots of the random effect solution versus the study estimate standard error before (left) and after (right) elimination of statistical outliers and study-estimates representing publication bias

eReferences

Supplement 2.

Data sharing statement


Articles from JAMA Pediatrics are provided here courtesy of American Medical Association

RESOURCES